Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
124.20    -5.80 (-4.46%)
Bid:
124.60
Ask:
125.00
Spread: 0.40 (0.321%)
Market Cap: £302.33m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

5 Feb 2024 07:00

RNS Number : 9356B
PureTech Health PLC
05 February 2024
 

5 February 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

2 February 2024

Number of ordinary shares purchased:

61,102

Highest price paid per share:

194.40p

Lowest price paid per share:

189.40p

Volume weighted average price paid per share:

191.32p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 19,349,968 ordinary shares in treasury and has 270,118,191 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 270,118,191 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

02/02/2024

08:02:36

239

193

AQXE

00388296125TRLO0.1.1

02/02/2024

08:22:34

235

194

XLON

00388300424TRLO0.1.1

02/02/2024

08:22:34

143

194

XLON

00388300425TRLO0.1.1

02/02/2024

08:22:34

637

194

XLON

00388300426TRLO0.1.1

02/02/2024

08:22:34

27

194

XLON

00388300427TRLO0.1.1

02/02/2024

08:22:34

1042

194

XLON

00388300428TRLO0.1.1

02/02/2024

08:23:21

100

193.8

XLON

00388300606TRLO0.1.1

02/02/2024

08:23:21

421

193.8

XLON

00388300607TRLO0.1.1

02/02/2024

09:00:04

139

194.4

BATE

00388305563TRLO0.1.1

02/02/2024

09:10:33

1

194.4

BATE

00388307285TRLO0.1.1

02/02/2024

09:10:33

395

194.4

BATE

00388307286TRLO0.1.1

02/02/2024

09:11:11

239

193.4

AQXE

00388307364TRLO0.1.1

02/02/2024

09:11:11

114

193.2

CHIX

00388307365TRLO0.1.1

02/02/2024

09:11:11

78

193.2

CHIX

00388307366TRLO0.1.1

02/02/2024

09:11:11

329

193.2

CHIX

00388307367TRLO0.1.1

02/02/2024

09:11:11

918

193.4

XLON

00388307368TRLO0.1.1

02/02/2024

09:11:11

1166

193.4

XLON

00388307369TRLO0.1.1

02/02/2024

09:21:40

118

193.6

TRQX

00388309042TRLO0.1.1

02/02/2024

09:39:33

3

192.6

XLON

00388311542TRLO0.1.1

02/02/2024

09:39:33

390

192.6

BATE

00388311544TRLO0.1.1

02/02/2024

09:39:33

117

192.6

BATE

00388311543TRLO0.1.1

02/02/2024

09:39:33

120

192.6

CHIX

00388311545TRLO0.1.1

02/02/2024

09:39:33

401

192.6

CHIX

00388311546TRLO0.1.1

02/02/2024

09:39:33

2081

192.6

XLON

00388311547TRLO0.1.1

02/02/2024

09:39:33

118

192.6

TRQX

00388311548TRLO0.1.1

02/02/2024

11:11:43

59

192.8

XLON

00388323495TRLO0.1.1

02/02/2024

11:27:59

142

192.4

TRQX

00388325981TRLO0.1.1

02/02/2024

11:27:59

94

192.4

TRQX

00388325982TRLO0.1.1

02/02/2024

11:28:00

181

192.8

XLON

00388325983TRLO0.1.1

02/02/2024

11:28:05

32

192.8

XLON

00388326012TRLO0.1.1

02/02/2024

12:37:02

604

192.8

CHIX

00388336278TRLO0.1.1

02/02/2024

12:40:54

38

193

XLON

00388337012TRLO0.1.1

02/02/2024

13:23:28

38

193.2

XLON

00388343412TRLO0.1.1

02/02/2024

13:28:24

239

193

AQXE

00388344182TRLO0.1.1

02/02/2024

13:28:24

521

193

CHIX

00388344183TRLO0.1.1

02/02/2024

13:28:24

521

193

BATE

00388344184TRLO0.1.1

02/02/2024

13:28:25

253

193.2

XLON

00388344185TRLO0.1.1

02/02/2024

13:28:31

224

193.2

XLON

00388344190TRLO0.1.1

02/02/2024

13:30:18

1700

192.6

XLON

00388344813TRLO0.1.1

02/02/2024

13:30:18

384

192.6

XLON

00388344814TRLO0.1.1

02/02/2024

13:30:34

768

193

CHIX

00388345053TRLO0.1.1

02/02/2024

13:30:37

1071

193

XLON

00388345201TRLO0.1.1

02/02/2024

13:30:40

190

193

XLON

00388345226TRLO0.1.1

02/02/2024

13:38:38

205

192.2

AQXE

00388347486TRLO0.1.1

02/02/2024

13:38:38

34

192.2

AQXE

00388347487TRLO0.1.1

02/02/2024

13:38:38

132

192.4

TRQX

00388347488TRLO0.1.1

02/02/2024

13:38:38

2084

192.2

XLON

00388347489TRLO0.1.1

02/02/2024

13:38:38

413

192

BATE

00388347490TRLO0.1.1

02/02/2024

13:38:38

521

192

CHIX

00388347491TRLO0.1.1

02/02/2024

13:38:38

305

192

CHIX

00388347492TRLO0.1.1

02/02/2024

13:38:38

47

192

BATE

00388347493TRLO0.1.1

02/02/2024

13:38:38

216

192

CHIX

00388347494TRLO0.1.1

02/02/2024

13:38:38

61

192

BATE

00388347495TRLO0.1.1

02/02/2024

13:39:05

521

191.4

BATE

00388347582TRLO0.1.1

02/02/2024

13:39:07

100

191.4

XLON

00388347587TRLO0.1.1

02/02/2024

13:57:44

163

191

AQXE

00388352646TRLO0.1.1

02/02/2024

13:57:44

76

191

AQXE

00388352647TRLO0.1.1

02/02/2024

13:57:44

1563

191

XLON

00388352648TRLO0.1.1

02/02/2024

13:57:44

294

191

XLON

00388352649TRLO0.1.1

02/02/2024

13:57:44

735

191

XLON

00388352650TRLO0.1.1

02/02/2024

13:57:44

60

191

XLON

00388352651TRLO0.1.1

02/02/2024

14:00:19

1

191

XLON

00388353382TRLO0.1.1

02/02/2024

14:09:44

288

191.4

XLON

00388355697TRLO0.1.1

02/02/2024

14:09:44

158

191.4

XLON

00388355696TRLO0.1.1

02/02/2024

14:17:04

626

191.4

XLON

00388357470TRLO0.1.1

02/02/2024

14:17:04

371

191.4

XLON

00388357471TRLO0.1.1

02/02/2024

14:17:04

642

191.4

XLON

00388357472TRLO0.1.1

02/02/2024

14:36:14

239

191

AQXE

00388369123TRLO0.1.1

02/02/2024

14:36:14

239

191

AQXE

00388369124TRLO0.1.1

02/02/2024

14:36:14

138

191

BATE

00388369125TRLO0.1.1

02/02/2024

14:36:14

383

191

BATE

00388369126TRLO0.1.1

02/02/2024

14:36:14

132

191

CHIX

00388369127TRLO0.1.1

02/02/2024

14:36:14

200

191

CHIX

00388369129TRLO0.1.1

02/02/2024

14:36:14

380

191

CHIX

00388369128TRLO0.1.1

02/02/2024

14:36:14

2605

191

XLON

00388369130TRLO0.1.1

02/02/2024

14:36:14

870

191

XLON

00388369131TRLO0.1.1

02/02/2024

14:36:14

429

191

XLON

00388369132TRLO0.1.1

02/02/2024

14:41:22

66

190.6

TRQX

00388372860TRLO0.1.1

02/02/2024

14:41:22

2605

190.6

XLON

00388372861TRLO0.1.1

02/02/2024

14:41:22

38

190.6

TRQX

00388372862TRLO0.1.1

02/02/2024

14:41:22

114

190.6

TRQX

00388372863TRLO0.1.1

02/02/2024

14:41:22

86

190.6

TRQX

00388372864TRLO0.1.1

02/02/2024

14:44:14

521

191

BATE

00388374733TRLO0.1.1

02/02/2024

14:44:16

939

191

XLON

00388374748TRLO0.1.1

02/02/2024

14:53:23

521

190.4

CHIX

00388380451TRLO0.1.1

02/02/2024

14:53:23

521

190

BATE

00388380452TRLO0.1.1

02/02/2024

14:53:23

521

190

BATE

00388380453TRLO0.1.1

02/02/2024

14:53:23

1416

190.2

XLON

00388380455TRLO0.1.1

02/02/2024

14:56:48

290

190.2

XLON

00388382608TRLO0.1.1

02/02/2024

14:56:48

94

190.2

XLON

00388382609TRLO0.1.1

02/02/2024

15:01:15

526

190.2

XLON

00388385215TRLO0.1.1

02/02/2024

15:01:15

537

190.2

XLON

00388385216TRLO0.1.1

02/02/2024

15:01:41

537

190.2

XLON

00388385386TRLO0.1.1

02/02/2024

15:02:45

198

189.6

AQXE

00388386147TRLO0.1.1

02/02/2024

15:02:45

41

189.6

AQXE

00388386148TRLO0.1.1

02/02/2024

15:02:50

186

189.6

XLON

00388386186TRLO0.1.1

02/02/2024

15:06:28

380

189.4

XLON

00388388263TRLO0.1.1

02/02/2024

15:06:28

260

189.6

XLON

00388388264TRLO0.1.1

02/02/2024

15:06:33

279

189.6

XLON

00388388292TRLO0.1.1

02/02/2024

15:06:39

3323

189.6

XLON

00388388364TRLO0.1.1

02/02/2024

15:25:10

261

189.8

XLON

00388400156TRLO0.1.1

02/02/2024

15:25:10

741

189.8

XLON

00388400157TRLO0.1.1

02/02/2024

15:33:41

177

190.2

XLON

00388404210TRLO0.1.1

02/02/2024

15:48:03

239

190.2

AQXE

00388410294TRLO0.1.1

02/02/2024

15:48:03

246

190.2

CHIX

00388410295TRLO0.1.1

02/02/2024

15:48:03

87

190.2

CHIX

00388410297TRLO0.1.1

02/02/2024

15:48:03

275

190.2

CHIX

00388410296TRLO0.1.1

02/02/2024

15:48:03

41

190.2

TRQX

00388410298TRLO0.1.1

02/02/2024

15:48:03

77

190.2

TRQX

00388410299TRLO0.1.1

02/02/2024

15:48:03

1200

190.2

XLON

00388410300TRLO0.1.1

02/02/2024

15:48:03

72

190.2

TRQX

00388410301TRLO0.1.1

02/02/2024

15:48:03

1405

190.2

XLON

00388410302TRLO0.1.1

02/02/2024

15:59:43

154

190.6

XLON

00388416661TRLO0.1.1

02/02/2024

16:08:13

107

190.6

AQXE

00388421159TRLO0.1.1

02/02/2024

16:08:13

119

190.6

BATE

00388421160TRLO0.1.1

02/02/2024

16:08:13

101

190.6

XLON

00388421161TRLO0.1.1

02/02/2024

16:08:13

298

190.6

XLON

00388421162TRLO0.1.1

02/02/2024

16:08:16

489

190.6

XLON

00388421202TRLO0.1.1

02/02/2024

16:08:44

132

190.6

AQXE

00388421347TRLO0.1.1

02/02/2024

16:08:44

241

190.6

BATE

00388421348TRLO0.1.1

02/02/2024

16:16:35

6

190.6

AQXE

00388426174TRLO0.1.1

02/02/2024

16:16:35

161

190.6

BATE

00388426175TRLO0.1.1

02/02/2024

16:16:35

521

190.6

CHIX

00388426176TRLO0.1.1

02/02/2024

16:16:35

445

190.6

BATE

00388426177TRLO0.1.1

02/02/2024

16:16:35

1563

190.6

XLON

00388426178TRLO0.1.1

02/02/2024

16:16:35

1042

190.6

XLON

00388426179TRLO0.1.1

02/02/2024

16:20:51

1162

190.6

XLON

00388430065TRLO0.1.1

02/02/2024

16:21:16

989

190.6

XLON

00388430417TRLO0.1.1

02/02/2024

16:21:39

746

190.2

CHIX

00388430658TRLO0.1.1

02/02/2024

16:21:39

1338

190.2

XLON

00388430659TRLO0.1.1

02/02/2024

16:21:39

57

190.2

XLON

00388430660TRLO0.1.1

02/02/2024

16:21:39

665

190.2

XLON

00388430662TRLO0.1.1

02/02/2024

16:29:05

3

190.4

XLON

00388436051TRLO0.1.1

02/02/2024

16:29:36

82

190.6

TRQX

00388436518TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFVTFVIFIIS
Date   Source Headline
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
21st Aug 202512:00 pmRNS-RPureTech Showcases Differentiated IPF Strategy
18th Aug 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.